Single answer
Is Altimmune Inc (ALT) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
Decision snapshot
Everything you need to act fast, in one glance.
What is the conclusion?
Right now our advanced algorithms say:
$1 invested is now $0.90 or -9.68%
(In 4 weeks 6 days 23 hours 39 minutes and 6 seconds .)
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Altimmune Inc is $20.00, which is $15.52 (345.93%) above the current price today's price.
Low target: $20.00 | High target: $20.00
Latest analyst updates
Recent rating and price target changes for this stock.
Company snapshot
A quick overview of the business and its public profile.
Altimmune Inc a clinical stage biopharmaceutical company focuses on developing treatments for obesity and liver diseases The companys lead product candidate pemvidutide proposed INN formerly known as ALT801 is a GLP1glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and nonalcoholic steatohepatitis It is also developing HepTcell an immunotherapeutic product candidate which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus The company was formerly known as Vaxin Inc and changed its name to Altimmune Inc in September 2015 Altimmune Inc was founded in 1997 is headquartered in Gaithersburg Maryland
Website: https://altimmune.com
Rates and inflation backdrop
US inflation for January 2026 was 0.17%. Over the last 12 months, inflation is 2.83%. The 10-year yield is 4.04 and is down -0.110 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.07. Cash flow to debt ratio: -4.19. Net profit margin: -419,575.00%. Inflation risk score: medium (0.70/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Altimmune Inc is $18.8M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
We cannot find data for Altimmune Inc 10 years ago, but if you had invested on 2017-05-26 when the price was $133.20, you would have made a loss of $128.64 per share or 96.58%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.